Status:
UNKNOWN
Investigating the Effects of Hyperoxia on Fractional Flow Reserve
Lead Sponsor:
Bayside Health
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Coronary artery disease (CAD) is a condition which refers to the narrowing of the small blood vessels that supplies blood and oxygen to the heart. It is a common cause of chest-pain related symptoms a...
Eligibility Criteria
Inclusion
- Adults ≥ 18 years of age, AND
- Undergoing elective coronary angiography
- Evidence of moderate (40%-79%) stenosis, requiring further routine assessment with FFR.
Exclusion
- Acute coronary syndrome
- Hypoxia with oxygen saturation measured on pulse oximeter \< 94% with the patient breathing air
- Altered conscious state
- Evidence of left ventricular failure or cardiogenic shock
- Unable to perform consent prior to procedure
- Known hypersensitivity to adenosine
- Sick sinus syndrome, second or third degree atrioventricular (A-V) block (except in patients with a functioning artificial pacemaker).
- Chronic Obstructive lung disease COPD or asthma
- Long QT syndrome
- Severe hypotension
- Concomitant use of dipyridamole
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01499316
Start Date
March 1 2014
End Date
December 1 2014
Last Update
March 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3004